Lineage Cell Therapeutics Receives CE Mark Approval for Renevia®

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/13/2026

1. CSCO
2. CBRS
3. COHR
4. EAT
5. WYFI
6. STUB
7. GO
8. CRS
9. ARX
10. FRMI

Go back to Lineage Cell Therapeutics Receives CE Mark Approval for Renevia®
(NYSE: LCTX) Delayed: 1.09 -0.01 (0.91%)
Previous Close $1.10    52 Week High $ 
Open $1.11    52 Week Low $ 
Day High $1.12    P/E N/A 
Day Low $1.09    EPS $ 
Volume 35,840       

(NYSE: LCTX) Delayed: 1.09 -0.01 (0.91%)
Previous Close $1.10    52 Week High $ 
Open $1.11    52 Week Low $ 
Day High $1.12    P/E N/A 
Day Low $1.09    EPS $ 
Volume 35,840